Published on Medical Design Technology (http://www.mdtmag.com)

Home > Amag Pharmaceuticals reports smaller losses

Amag Pharmaceuticals reports smaller losses

Mass High Tech: The Journal of New England Technology

Amag Pharmaceuticals Inc. (Nasdaq: AMAG) reported a 39 percent spike in revenue and a 77 percent reduction in operating loss for the first nine months of the year as compared with the same time last year due to strong sales of its drug, Feraheme.

Source URL (retrieved on 05/18/2013 - 4:22am): http://www.mdtmag.com/news/2012/11/amag-pharmaceuticals-reports-smaller-losses?qt-recent_content=0